EGFR通过在氨酸360和401中酸化TNFR1来抑制TNF-α介导的途径
Young Woo Nam1, June-Ha Shin1, Seongmi Kim1
1Department of Biochemistry, College of Life Science and Technology, Institute for Bio-medical Convergence Science and Technology, Yonsei University, Seoul, Republic of Korea.
Cell death and differentiation
|May 24, 2024
概括
皮表皮生长因子受体 (EGFR) 直接化瘤亡因子受体1 (TNFR1),调节细胞死亡途径. 抑制EGFR阻断了这种相互作用,影响NF-κB信号传递和亡.
科学领域:
- 细胞生物学 细胞生物学
- 分子信号传输的方法
- 免疫学 免疫学 免疫学
背景情况:
- 由TNF-α激活瘤缩因子受体1 (TNFR1),启动NF-κB信号传递和细胞死亡.
- 人们了解TNFR1下游的机制,但其直接调节仍然不清楚.
研究的目的:
- 调查TNFR1.1.的直接调节情况.
- 阐明表皮生长因子受体 (EGFR) 在TNFR1-介导信号传递中的作用.
主要方法:
- 研究了EGFR的激酶域与TNFR1.1的相互作用.
- 使用EGFR抑制剂 (erlotinib,gefitinib) 来阻止相互作用.
- 在TNFR1的死亡域上检查了酸化部位 (Tyr 360,401).
- 对NF-κB通路,亡和亡的评估影响.
- 在老鼠模型中研究了尸性皮肤炎症的影响.
主要成果:
- 在Tyr 360和401的EGFR直接化TNFR1.
- 抑制EGFR可以防止TNFR1的酸化和随后的信号传递.
- 化TNFR1抑制NF-κB通路,亡和亡.
- 在小鼠中,EGF治疗减轻了TNF-α诱导的死亡性皮肤炎症.
结论:
- 通过酸化,EGFR直接调节TNFR1的活动.
- 这种相互作用调节NF-κB信号传递,亡和亡.
- EGFR在控制与TNF-α相关的细胞死亡途径方面发挥着新的作用.
相关概念视频
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Receptor Tyrosine Kinases
12.7K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.7K
MAPK Signaling Cascades
5.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K


